Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9393256 Methods for treating HCV

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

July 19, 2016

Patent Application Number

13875252

Date Filed

May 1, 2013

Patent Citations Received

US Patent 12012431 Methods of preparing 1′-cyano nucleosides

0

US Patent 11939347 1′-cyano nucleoside analogs and uses thereof

0

US Patent 11975017 Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections

0

US Patent 11975012 Remdesivir treatment methods

0

US Patent 11660307 Methods for treating SARS CoV-2 infections

0

US Patent 11701372 Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs

0

US Patent 11707479 Combination formulation of two antiviral compounds

0

US Patent 11780844 Compounds and methods for treatment of viral infections

...

Patent Primary Examiner

Jeffrey S Lundgren

Patent abstract

This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9393256 Methods for treating HCV

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool